Donor-acceptor type thermally activated delayed fluorescent emitters based on imidazo[1,2-F]phenanthridine and analogues for full color displays and lighting applications.

Tricyclic compounds, and in particular novel dibenzoxazepin derivates are disclosed herein, which were quite surprisingly found as having OMA1 and/or OPA1 modulatory properties. Compounds of present invention may provide useful for the treatment of certain conditions and diseases, which are amenable to OMA1 and/or OPA1-modulatory therapies. Such conditions may include conditions and diseases prevalent in the elderly, including cancer. Pharmaceutical compositions comprising compounds of present invention may be combined with other treatments or further comprise other pharmaceutically active ingredients.

Tricyclic compounds, and in particular novel dibenzoxazepin derivates are disclosed herein, which were quite surprisingly found as having OMA1 and/or OPA1 modulatory properties. Compounds of present invention may provide useful for the treatment of certain conditions and diseases, which are amenable to OMA1 and/or OPA1-modulatory therapies. Such conditions may include conditions and diseases prevalent in the elderly, including cancer. Pharmaceutical compositions comprising compounds of present invention may be combined with other treatments or further comprise other pharmaceutically active ingredients.

The present invention relates to substituted macrocyclic indole derivatives of general formula (I):

##STR00001##

in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.

The present invention relates to substituted macrocyclic indole derivatives of general formula (I):

##STR00001##

in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.

A fluorescent material and a method of synthesizing thereof are provided. The fluorescent material includes a formula (1) as follows:

##STR00001##

formula (1), and Y is N or B; X.sub.1 and X.sub.2 are the same or different; X.sub.1 and X.sub.2 are selected from C or Si; R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are the same or different; R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are selected from a hydrogen atom, an alkyl group, an aromatic hydrocarbon group, or a heteroaryl group; R.sub.5, R.sub.6, R.sub.7, and R.sub.8 are the same or different; R.sub.5, R.sub.6, R.sub.7, and R.sub.8 are selected from an alkyl group, an aromatic hydrocarbon group, or a heteroaryl group; or R.sub.5 and R.sub.6 form a cyclic group; or R.sub.7 and Rs form a cyclic group.

A fluorescent material and a method of synthesizing thereof are provided. The fluorescent material includes a formula (1) as follows:

##STR00001##

formula (1), and Y is N or B; X.sub.1 and X.sub.2 are the same or different; X.sub.1 and X.sub.2 are selected from C or Si; R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are the same or different; R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are selected from a hydrogen atom, an alkyl group, an aromatic hydrocarbon group, or a heteroaryl group; R.sub.5, R.sub.6, R.sub.7, and R.sub.8 are the same or different; R.sub.5, R.sub.6, R.sub.7, and R.sub.8 are selected from an alkyl group, an aromatic hydrocarbon group, or a heteroaryl group; or R.sub.5 and R.sub.6 form a cyclic group; or R.sub.7 and Rs form a cyclic group.

The present invention relates to compounds suitable for use in electronic devices, and to electronic devices, especially organic electroluminescent devices, comprising these compounds.

The present invention relates to compounds suitable for use in electronic devices, and to electronic devices, especially organic electroluminescent devices, comprising these compounds.

The present invention provides a novel compound that has anti-RSV activity and that is useful in the prevention or treatment of an infection in which viruses of the subfamily Pneumovirinae, including respiratory syncytial virus (RSV), are involved, or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides a compound represented by formula (I):

##STR00001##

or a pharmaceutically acceptable salt thereof.